Latest News
Feature
DEA moves Epidiolex to schedule V, clearing the way for marketing
The cannabis-derived drug to treat pediatric seizures should be available within 6 weeks.
Latest News
House, Senate agree on broad opioid legislation
Huge bill to address the opioid epidemic contains many provisions that will affect physicians.
From the Journals
Atrial fib guidelines may fall short on oral anticoagulation
Oral anticoagulation threshold according to CHA2DS2-VASc score varied widely after accounting for varying stroke rates in published studies.
Feature
5 things to know about Trump’s new ‘public charge’ immigration proposal
The proposal has spurred intense criticism from Democrats, anti-poverty activists, health care organizations, and immigrants’ rights advocates,...
Conference Coverage
Signs point to growing abuse of gabapentinoids in the U.S.
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and...
Latest News
Proposal to change Part B drug WAC-based reimbursement draws criticism
The ACR, ASCO, AMA, and others argued against the proposal in comments to CMS.
News
ADHD in the long term
From the Journals
Bacteremic sepsis in ALL linked to later cognitive issues
Patients who survive acute lymphoblastic leukemia still may face cognitive impairment later in life because of sepsis during treatment.
Conference Coverage
Ketamine infusions may be helpful in central sensitization pain syndromes
FDA/CDC
FDA review supports Nuplazid’s safety
From the Journals
Clearance rates for some antiepileptic drugs rise during pregnancy